# Radio-Immunotherapy Before Cystectomy in Locally Advanced Urothelial Carcinoma of the Bladder

> **NCT03529890** · PHASE2 · UNKNOWN · sponsor: **Technical University of Munich** · enrollment: 33 (estimated)

## Conditions studied

- Urinary Bladder Cancer

## Interventions

- **DRUG:** Nivolumab
- **RADIATION:** Radiation therapy of the pelvis
- **PROCEDURE:** Radical cystectomy with standardized pelvic lymphadenectomy

## Key facts

- **NCT ID:** NCT03529890
- **Lead sponsor:** Technical University of Munich
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-02-04
- **Primary completion:** 2022-04-14
- **Final completion:** 2023-08
- **Target enrollment:** 33 (ESTIMATED)
- **Last updated:** 2022-10-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03529890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03529890, "Radio-Immunotherapy Before Cystectomy in Locally Advanced Urothelial Carcinoma of the Bladder". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT03529890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*